These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 33025481)
1. A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients. Goyal A; Puri S; Marshall A; Valassiadou K; Hoosein MM; Carmichael AR; Erdelyi G; Sharma N; Dunn J; York J Breast Cancer Res Treat; 2021 Jan; 185(2):433-440. PubMed ID: 33025481 [TBL] [Abstract][Full Text] [Related]
2. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer. Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847 [TBL] [Abstract][Full Text] [Related]
3. Carbon tattooing of axillary lymph nodes in breast cancer patients before neoadjuvant chemotherapy: A retrospective analysis. Porpiglia M; Borella F; Chieppa P; Brino C; Ala A; Marra V; Castellano I; Benedetto C Tumori; 2023 Jun; 109(3):301-306. PubMed ID: 35751383 [TBL] [Abstract][Full Text] [Related]
4. False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy. de Boniface J; Frisell J; Kühn T; Wiklander-Bråkenhielm I; Dembrower K; Nyman P; Zouzos A; Gerber B; Reimer T; Hartmann S Breast Cancer Res Treat; 2022 Jun; 193(3):589-595. PubMed ID: 35451733 [TBL] [Abstract][Full Text] [Related]
5. Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment. Natsiopoulos I; Intzes S; Liappis T; Zarampoukas K; Zarampoukas T; Zacharopoulou V; Papazisis K Clin Breast Cancer; 2019 Jun; 19(3):208-215. PubMed ID: 30922804 [TBL] [Abstract][Full Text] [Related]
6. Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery. Allweis TM; Menes T; Rotbart N; Rapson Y; Cernik H; Bokov I; Diment J; Magen A; Golan O; Levi-Bendet N; Givon Madhala O; Grubstein A Eur J Surg Oncol; 2020 Jun; 46(6):1041-1045. PubMed ID: 31801656 [TBL] [Abstract][Full Text] [Related]
7. Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients. Choy N; Lipson J; Porter C; Ozawa M; Kieryn A; Pal S; Kao J; Trinh L; Wheeler A; Ikeda D; Jensen K; Allison K; Wapnir I Ann Surg Oncol; 2015 Feb; 22(2):377-82. PubMed ID: 25164040 [TBL] [Abstract][Full Text] [Related]
8. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results. Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL Surg Oncol; 2021 Sep; 38():101636. PubMed ID: 34303211 [TBL] [Abstract][Full Text] [Related]
9. Ultrasound-Guided Fine-Needle Aspiration of Non-palpable and Suspicious Axillary Lymph Nodes with Subsequent Removal after Tattooing: False-Negative Results and Concordance with Sentinel Lymph Nodes. Kim WH; Kim HJ; Jung JH; Park HY; Lee J; Kim WW; Park JY; Cheon H; Lee SM; Cho SH; Shin KM; Kim GC Ultrasound Med Biol; 2017 Nov; 43(11):2576-2581. PubMed ID: 28830644 [TBL] [Abstract][Full Text] [Related]
10. Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node. Patel R; MacKerricher W; Tsai J; Choy N; Lipson J; Ikeda D; Pal S; De Martini W; Allison KH; Wapnir IL Ann Surg Oncol; 2019 Aug; 26(8):2452-2458. PubMed ID: 31087176 [TBL] [Abstract][Full Text] [Related]
11. Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients. Pinto CS; Peleteiro B; Pinto CA; Osório F; Costa S; Magalhães A; Mora H; Amaral J; Gonçalves D; Fougo JL Breast Cancer; 2022 Jul; 29(4):709-719. PubMed ID: 35304711 [TBL] [Abstract][Full Text] [Related]
12. Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients. Park S; Koo JS; Kim GM; Sohn J; Kim SI; Cho YU; Park BW; Park VY; Yoon JH; Moon HJ; Kim MJ; Kim EK Cancer Res Treat; 2018 Jul; 50(3):801-812. PubMed ID: 28814071 [TBL] [Abstract][Full Text] [Related]
13. Feasibility of preoperative tattooing of percutaneously biopsied axillary lymph node: an experimental pilot study. Sattar AK; Ali B; Masroor I; Afzal S; Tariq MU; Idrees R; Uzzaman M; Khalid W Pilot Feasibility Stud; 2020; 6():140. PubMed ID: 32983557 [TBL] [Abstract][Full Text] [Related]
14. Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer. Nakamura R; Yamamoto N; Miyaki T; Itami M; Shina N; Ohtsuka M Breast Cancer; 2018 Jan; 25(1):86-93. PubMed ID: 28735457 [TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer. Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301 [TBL] [Abstract][Full Text] [Related]
17. Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy. Balasubramanian R; Morgan C; Shaari E; Kovacs T; Pinder SE; Hamed H; Sever AR; Kothari A Eur J Surg Oncol; 2020 Jun; 46(6):1028-1033. PubMed ID: 31879050 [TBL] [Abstract][Full Text] [Related]
18. Development of a predictive score of axillary lymph node dissection based on targeted axillary dissection in patients with breast cancer diagnosis, affected lymph nodes, and neoadjuvant treatment. Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL Surg Oncol; 2021 Sep; 38():101629. PubMed ID: 34171793 [TBL] [Abstract][Full Text] [Related]
19. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis. Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364 [TBL] [Abstract][Full Text] [Related]
20. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice. Lee SB; Yu JH; Park H; Kim HJ; Park SH; Chae BJ; Youn HJ; Jung SY; Kim EK; Jung YS; Son BH Asian J Surg; 2019 Jan; 42(1):314-319. PubMed ID: 30049563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]